Iconiq Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,733
Closed -$1.94M 248
2025
Q2
$1.94M Buy
12,733
+2,642
+26% +$406K 0.03% 62
2025
Q1
$1.67M Buy
10,091
+5,375
+114% +$841K 0.03% 67
2024
Q4
$682K Sell
4,716
-217
-4% -$33.6K 0.01% 113
2024
Q3
$799K Buy
4,933
+3,225
+189% +$514K 0.02% 67
2024
Q2
$250K Buy
+1,708
New +$254K 0.01% 87

Other funds holding JNJ

Iconiq Capital's JNJ Position: Q3 2025 in Review

Iconiq Capital sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 12,733 shares — an estimated $1.94M sold.

Iconiq Capital first reported a position in JNJ in Q2 2024 and held it in 5 quarters. The position peaked at $1.94M in Q2 2025. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Iconiq Capital reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Iconiq Capital sold 12,733 Johnson & Johnson shares in Q3 2025, an estimated $1.94M.
  • Iconiq Capital first reported a position in Johnson & Johnson in Q2 2024 and held it in 5 quarters.
  • Iconiq Capital's Johnson & Johnson position peaked at $1.94M in Q2 2025.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Iconiq Capital's 13F filing for Q3 2025, filed 14 Nov 2025.